Navigating the Increasing Complexity of Therapeutic Sequencing for Relapsed/Refractory Multiple Myeloma
OncLive,
The treatment landscape of relapsed/ refractory multiple myeloma (RRMM) has undergone rapid changes over the past 2 decades…
The treatment landscape of relapsed/ refractory multiple myeloma (RRMM) has undergone rapid changes over the past 2 decades…
August 16, 2016 Addition of Elotuzumab to Bortezomib/Dexamethasone Improves Survival in Relapsed/Refractory Multiple Myeloma…
April 19, 2016 The addition of elotuzumab to bortezomib and dexamethasone prolongs progression-free survival without worsening…